Ex vivo assessment of polyol coated-iron oxide nanoparticles for MRI diagnosis applications: Toxicological and MRI contrast enhancement effects

Oscar Bomati-Miguel, Nuria Miguel-Sancho, Ibane Abasolo, Ana Paula Candiota, Alejandro G. Roca, Milena Acosta, Simó Schwartz, Carles Arus, Clara Marquina, Gema Martinez, Jesus Santamaria

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Abstract

Polyol synthesis is a promising method to obtain directly pharmaceutical grade colloidal dispersion of superparamagnetic iron oxide nanoparticles (SPIONs). Here, we study the biocompatibility and performance as T2-MRI contrast agents (CAs) of high quality magnetic colloidal dispersions (average hydrodynamic aggregate diameter of 16-27 nm) consisting of polyol-synthesized SPIONs (5 nm in mean particle size) coated with triethylene glycol (TEG) chains (TEG-SPIONs), which were subsequently functionalized to carboxyl-terminated meso-2-3-dimercaptosuccinic acid (DMSA) coated-iron oxide nanoparticles (DMSA-SPIONs). Standard MTT assays on HeLa, U87MG, and HepG2 cells revealed that colloidal dispersions of TEG-coated iron oxide nanoparticles did not induce any loss of cell viability after 3 days incubation with dose concentrations below 50 μg Fe/ml. However, after these nanoparticles were functionalized with DMSA molecules, an increase on their cytotoxicity was observed, so that particles bearing free terminal carboxyl groups on their surface were not cytotoxic only at low concentrations (<10 μg Fe/ml). Moreover, cell uptake assays on HeLa and U87MG and hemolysis tests have demonstrated that TEG-SPIONs and DMSA-SPIONs were well internalized by the cells and did not induce any adverse effect on the red blood cells at the tested concentrations. Finally, in vitro relaxivity measurements and post mortem MRI studies in mice indicated that both types of coated-iron oxide nanoparticles produced higher negative T2-MRI contrast enhancement than that measured for a similar commercial T2-MRI CAs consisting in dextran-coated ultra-small iron oxide nanoparticles (Ferumoxtran-10). In conclusion, the above attributes make both types of as synthesized coated-iron oxide nanoparticles, but especially DMSA-SPIONs, promising candidates as T2-MRI CAs for nanoparticle-enhanced MRI diagnosis applications. © 2014 Springer Science+Business Media.
Original languageEnglish
JournalJournal of Nanoparticle Research
Volume16
DOIs
Publication statusPublished - 1 Jan 2014

Keywords

  • Contrast agents for nanoparticle-enhanced magnetic resonance imaging
  • Hemolysis tests
  • In vitro cytotoxicity
  • Nanomedicine
  • Polyol-mediated synthesis
  • Superparamagnetic iron oxide nanoparticles

Fingerprint Dive into the research topics of 'Ex vivo assessment of polyol coated-iron oxide nanoparticles for MRI diagnosis applications: Toxicological and MRI contrast enhancement effects'. Together they form a unique fingerprint.

Cite this